Oncology Institute (TOI) Operating Leases (2022 - 2026)

Oncology Institute (TOI) has 5 years of Operating Leases data on file, last reported at $18.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 12.75% year-over-year to $18.8 million; the trailing twelve-month figure through Mar 2026 stood at $18.8 million (down 12.75% YoY), and the FY2025 full-year result was $19.1 million, down 17.62% from the prior year.
• Operating Leases for Q1 2026 stood at $18.8 million, down from $19.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $32.6 million in Q2 2023 and bottomed at $14.6 million in Q2 2022.
• The 5-year median for Operating Leases is $22.1 million (2022), against an average of $23.6 million.
• The widest annual swing landed in 2023, when Operating Leases surged 123.4%; it then plunged 35.71% in 2025.
• A 5-year view of Operating Leases shows it stood at $22.1 million in 2022, then gained by 20.06% to $26.5 million in 2023, then declined by 12.32% to $23.2 million in 2024, then declined by 17.62% to $19.1 million in 2025, then dropped by 1.51% to $18.8 million in 2026.
• The last three Operating Leases figures came in at $18.8 million (Q1 2026), $19.1 million (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.

Peer Comparison